SUMMARY
Tricyclic antidepressant overdose is a relatively common cause of admission to the intensive care unit, but uncommonly causes ECG changes consistent with the Brugada syndrome. This case reports Brugada ECG changes in a 48-year-old man with a multidrug overdose that included a tricyclic antidepressant. We consider the current clinical knowledge on this subject, with a view to raising awareness of the mode of presentation of this uncommon cardiac disease for intensivists and anaesthetists alike.
CASE HISTORY
A 48-year-old man was admitted to the emergency department at 2100 hours following an overdose of an uncertain quantity of diazepam, zopiclone, nortriptyline and paroxetine at home. His other past history included hypertension and episodes of non-cardiac chest pain, which had been investigated five months earlier with a negative exercise tolerance test for ischaemia and a structurally normal heart on transthoracic echocardiography.
In the Emergency Department his respiratory rate was 16 per minute, maintaining saturations of 98% on oxygen, blood pressure (BP) 132/94 mmHg and heart rate (HR) 72 b/min. His Glasgow Coma Score (GCS) was 13/15. The rest of the examination was normal.
Investigations at that time showed normal electrolytes and glucose. Blood gas analysis on room air showed a pH 7.37, P a CO 2 6.4 kPa, P a O 2 9.0 kPa, and lactate 0.9 mmol/l. The serum toxicology screen was positive only for tricyclic antidepressants (unfortunately quantitative levels for tricyclics were unavailable at this hospital). The chest X-ray showed no abnormality. The initial ECG is shown ( Figure 1 ) with a normal QRS duration of 0.12 seconds.
The plan was to observe him in the Emergency Department overnight with psychiatry follow-up the following day.
At 0700 the following morning his oxygen saturations suddenly declined to 70% while on oxygen at 4 l/min. He continued to maintain his own airway, his RR was 20 per minute with coarse breath sounds at the left base. HR was 90 b/min, BP 100/60 mmHg. GCS was 11/15. A repeat chest X-ray demonstrated bibasal atelectasis.
This was thought to be an aspiration event. Continuous positive airway pressure (CPAP) of 7.5 cm H 2 O was commenced with an FiO 2 of 1.0. His saturations improved to 97% on this regimen and the Intensive Care Unit was requested to be involved with his further management.
He was subsequently admitted to the ICU at 0900 for CPAP and intravenous amoxycillin and clavulanic acid, but a declining GCS necessitated intubation and mechanical ventilation shortly after admission. The admission ECG showed isolated ST elevation of <1 mm with concave ST elevation in V2, a QRS duration of 0.12 s, QTc of 0.44 s and a normal PR interval. The troponin I was <0.3 µg/l (0-2.0 µg/l).
He remained stable and a repeat chest X-ray re-vealed some consolidation in the right upper zone and left perihilar region. His ventilation was weaned and he was extubated 22 hours after his admission to ICU at 0700, with stable clinical parameters. However, five hours after extubation he became acutely dyspnoeic with a very transient loss of consciousness, but denied chest pain or palpitations with this event.
His oxygen saturation was 94% on oxygen at 10 l/min via Hudson mask, HR 105 b/min sinus rhythm, BP125/65 mmHg, GCS 15/15 and he remained afebrile.
A repeat chest X-ray was unchanged. Repeat electrolytes and glucose were normal, pH 7.41, P a CO 2 5.6 kPa, P a O 2 14.3 kPa, and troponin I 0.9 µg/l (0-2.0 µg/l). A repeat ECG was performed ( Figure 2 ).
The ECG showed J point elevation with downsloping ST segment elevation in V1-V2 and T wave inversion. The PR interval was unchanged, QRS duration 0.12 s and QTc 0.46 s. He received aspirin 300 mg and an urgent cardiology opinion was sought regarding potential intervention for acute myocardial ischemia. Upon review of the patient and ECG, the cardiologists considered the ECG changes were not ischaemic but typical of the Brugada pattern, a potentially proarrhythmogenic repolarization abnormality that has been described with tricyclic use and overdose.
He was observed on the ICU for a further 24 hours without further event, arrhythmia or troponin rise. He remained off his nortriptyline and was discharged from the ICU to the coronary care unit whereupon his ECG returned to normal over the next four days. He was subsequently discharged to the care of the psychiatrists. Two years later he continues without nortriptyline and has had no further events.
DISCUSSION
The Brugada syndrome was first described by Brugada and Brugada in 1992 1 . The ECG pattern is characterized by a J wave amplitude of 2 mm, ST elevation, which is coved or saddlebacked and can be down-sloping with T wave changes. The changes must occur in two or more right precordial leads 2 . Antzelevitch and co-workers report that although a right bundle branch block (RBBB) pattern may become apparent with Brugada ECG changes, by strict definition of a RBBB, this frequently does not occur 3 . In our case there were convincing changes in leads V1-V2, and despite an apparent RBBB morphology in these leads the QRS duration was unchanged at 0.12 s. Brugada syndrome is present when these ECG changes occur with a clinical history of VF/VT, a history of syncope or a family history of the ECG changes or of sudden cardiac death. The history and ECG changes must occur in the absence of structural heart disease or conditions known to cause ST changes 2 . The Brugada syndrome is believed to account for 4 to 12% of all sudden cardiac deaths and 20% of deaths in patients with structurally normal hearts. It has a population incidence of 5 per 10,000 with a strong male predominance 3 . The syndrome appears to have a greater prevalence in people from South East Asia, where the ratio of males to females presenting with the syndrome is 8:1 with an average age of 40 years 1 . The Brugada syndrome has a genetic basis with a number of mutations identified in the SCN5A gene that codes for the α subunit of the cardiac sodium channel. It has an autosomal dominant inheritance with variable penetrance 4 . It is somewhat interesting to note that mutations in this gene with subsequent cardiac sodium channel dysfunction are involved in a variant of the Long QT syndrome (LQT3) 5 . The electrophysiological basis for the ECG changes is located in the right ventricle, particularly the epicardium of the right ventricular outflow tract, thus accounting for changes in the right precordial leads. There are two theories. One suggests that there is a conduction delay within the wall of the right ventricle that generates a voltage difference and current flow at a time when the ECG is normally isoelectric 6 . The other theory suggests the cause is a reduced sodium influx in phase 0 of the cardiac action potential. With subsequent activation of the transient outward potassium channels in phase 1 there is a greater degree of repolarization and therefore a reduced activation of the L type calcium channels during phase 2. This creates a voltage difference between the faster repolarizing epicardium and the endocardium 7 . In a recent study of patients with flecainide-induced Brugada pattern, Tukkie and co-workers, using tissue Doppler echocardiography, demonstrated that both these mechanisms may be active 8 . Re-excitation dysrhythmias in the form of polymorphic VT/VF can be generated when there is a heterogeneity of repolarized and refractory sites in the epicardium that give rise to closely coupled ventricular ectopic beats 7 . There appears to be a spectrum of the disease with the risk of developing a malignant arrhythmia being greatest in those where the ECG manifestations occur spontaneously with a prior history of syncope 9 . Brugada and colleagues also identified the electrical inducibility of a sustained ventricular arrhythmia as a strong predictor of future events, in their follow-up of 547 patients over a mean period of 24 months. The incidence of cardiac events in the presence of an abnormal ECG, syncope history and inducibility of ventricular arrhythmias was 27.2%, which is six times that of non-inducible individuals 10 . Those patients with a normal baseline ECG, but with Brugada pattern in the presence of sodium channel blockade (Type Ia and Ic antiarrhythmic drugs) are considered at lowest risk of future cardiac events 9, 10 . Amongst many actions, tricyclic antidepressants have a potent use-dependent inhibitory action on the cardiac sodium channel near therapeutic concentrations 11 . Nau and co-workers determined the potency of amitriptyline on human heart sodium channels to be one order greater than that of bupivacaine and cocaine, with a high affinity for the sodium channel in the inactivated state 11 . The Brugada pattern has been described following routine tricyclic antidepressant administration 12 and in overdose 13 . The Brugada pattern has also been described following the epidural infusion of 0.125% bupivacaine and 2.5 µg/ml fentanyl 14 , and is thought to be due to the greater affinity of bupivacaine for sodium channels than the Ib antiarrhythmic drug lignocaine. A number of other factors have also been implicated in the expression of the Brugada pattern including vagotonic agents, α-agonists, β-blockers, antihistamines, cocaine toxicity and fever 3 . There is no current pharmacological management for this condition. Patients with a prior history of sudden cardiac death or ventricular tachycardia or those considered to be at high risk for such events should be managed with an implanted automatic cardiac defibrillator. Brugada et al advocate that the high risk group should include all patients with inducible sustained ventricular arrhythmias and those with a spontaneous ECG pattern with a history of syncope regardless of inducibility 10 . There is a report of disappearance of the Brugada pattern in two individuals who had surgical castration as treatment for their prostate cancer 15 . This could suggest an association with testosterone and may explain the male preponderance. But it is unlikely to be an agreeable alternative to an implantable defibrillator.
In the event that the Brugada ECG pattern occurs through the therapeutic or toxic administration of the aforementioned agents, the identified agent should be immediately stopped and the patient should have continuous ECG monitoring until the Brugada changes resolve 2 . Initial treatment of life-threatening ventricular arrhythmias should be with DC cardioversion. Isoprenaline by low dose infusion (0.15 µg/min) was effective in preventing recurrent episodes of VF (up to 11 episodes an hour) in a Brugada syndrome patient with an "electrical storm" induced by bronchitis 16 . The action of isoprenaline increases the inward calcium current during phase 2 of the cardiac action potential and this reduces the voltage gradient between the epicardium and endocardium, resulting in a reduction in ST elevation in the Brugada ECG 8, 16 . All patients should be subsequently referred for a cardiology opinion for potential electrophysiology studies. The controversy that exists is whether to investigate assymptomatic patients who display the Brugada pattern only with an inducing agent where the only current therapy is an implantable cardiac defibrillator 2, 17 . The cause of our patient's transient loss of consciousness was not resolved. It raises the possibility of an unsustained arrhythmia or an unrelated event that serendipitously led us to the ECG findings.
We initially considered that the Brugada ECG pattern may have been induced by an overdose of the tricyclic, nortriptyline. While there was no quantitative analysis of plasma tricyclic antidepressant level, he did have a normal ECG at admission; he received only drugs for intubation (thiopentone/suxamethonium), sedation (morphine/midazolam) and antibiotics (amoxycillin/clavulanic acid) and had a positive tricyclic screen.
It is difficult to explain the delay in the presentation (40 hours) of the ECG changes in relation to the time of ingestion of nortriptyline. Possible reasons include delayed absorption due to the other medications taken at the time of the overdose and effect of sedative drugs in the ICU. Of concern is that the ECG changes occurred at time when plasma tricyclic antidepressant levels would normally be low after an overdose situation and that there were no ECG features of significant tricyclic antidepressant toxicity at presentation. Furthermore if this was a spontaneous presentation of the Brugada pattern, it presented with a syncopal episode potentially increasing his risk of future arrhythmias.
Our patient is currently being re-evaluated by the cardiology service.
CONCLUSION
There is little written about Brugada syndrome in the anaesthetic and intensive care literature, but because of the risk of sudden death it is important for clinicians to be aware of and recognise the characteristic ECG pattern. The pattern may spontaneously come and go or be induced in susceptible individuals with a number of agents that are used in anaesthesia and intensive care practice. Further investigation may be warranted, but given that the only current treat-ment is an implantable cardiac defibrillator, with economic constraints, lifestyle changes and potential for complications, an implantable defibrillator is offered only to those patients considered at high risk of future events. With time, though, we may expect further therapies to evolve together with a greater awareness of at risk patients.
